Redeye briefly comments on yesterday’s news that the final reporting of the ELC-100 study will be po...
Redeye comments on Annexin's Q1 report and recent events in the company.
VBG Group redovisade en omsättning på 1 351 MSEK i Q1, en organisk minskning med 12,9 % jämfört med ...
Endomines published its updated strategy for 2025–2029, which largely builds on the previous one, wi...
Biovica sets precise sales targets after recording SEK 8.
Redeye comments on Monday’s milestone payment of SEK12m from Infiniteria.
Redeye is positive about Neola Medical’s agreement with Children’s Regional Hospital in New Jersey, ...
Redeye comments on Xbrane following its SEK240m directed share issue targeting both institutional an...
Redeye provides a brief on yesterday’s news from Nitro Games, which announced that publishing rights...
CapMan is a leader in the Nordic investment and asset management space with AuM of EUR 6.
Systemair redovisar ett stabilt fjärde kvartal 2024/25 med förbättrade marginaler och starkt kassafl...
Den välannonserade svackan i Q1 blev djupare än vi tänkt oss, men ruckar inte på bilden av ett välmå...
Redeye comments on GiG Software’s announcement of a directed share issue which strengthens the compa...
Redeye is only making minor changes to forecasts and valuation following the 2024/05 full year repor...
Redeye is positive about Optomed´s launch of its next-gen camera, Optomed Lumo.
Redeye provides commentary on NextCell following recent newsflow including raising SEK36.
Redeye comments on this morning’s news that Kancera has received positive feedback on the planned cl...
With its updated core business strategy, Enersense is extending its focus from construction to maint...
Redeye provides a brief comment on today’s news regarding Scibase's first order in Italy.
